HIV prevention clinical trials’ community engagement guidelines: inequality, and ethical conflicts
In 2004 and 2005, the first clinical trials were launched to investigate the use of tenofovir for HIV prevention in Cambodia, Cameroon, Nigeria and Thailand. Controversies erupted over the ethical integrity of the research protocol. We reflect on the events that led to the controversies and identifi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Global Bioethics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/11287462.2020.1773061 |